Therapeutic strategies targeting PKR1 could be important to treat obesity and obesity-associated insulin resistance, since PKR1 signaling suppresses appetite, reduces adipocyte expansion, promotes normal fat storage, and increases insulin sensitivity. This evidence concerns the gene INS and obesity disorder.